跳至主要内容
临床试验/CTRI/2023/09/057283
CTRI/2023/09/057283尚未招募2/3 期

A comparative clinical study to evaluate the effect of kayaseka followed by nitya virechana and sadyo virechana in amavata (Rheumatoid arthritis)

Priyanka Kalal1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年9月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Reduction in sandhi shotha,sandhi shoola,sandhi stabdatha

研究概览

简要总结

Amavata is a aama pradoshaja vikara, caused by agnimandya, which leads to accumulation of ama in shleshmasthana and prakopa of vata dosha, resulting in angamarda, aruchi, trushna, alasya, gourav, jwara,apaka and shoonangata which closely resembles the rheumatological disorder called Rheumatoid arthritis.As Swedana and Virechana are two prime procedures mentioned in the chikitsa sutra of Amavata, the present study focuses on evaluating the effect of Kayaseka with Dashamoola kashaya followed by Nitya virechana and Sadyo virechana with Nimbamrutadi eranda taila in Amavata.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Subjects aged between 18-60 years of both genders.
  • 2.Subjects fulfilling the diagnostic criteria of Amavata.
  • 3.Subjects indicated for Kayaseka and Virechana.

排除标准

  • 1.Subjects associated with uncontrolled Diabetes Mellitus, Hypertension, Cardiac diseases and other systemic disorders.
  • 2.Rheumatoid arthritis patients with gross deformity.
  • 3.Pregnant and lactating women.
  • • Patient with skin lesions, cuts, wounds.

结局指标

主要结局

Reduction in sandhi shotha,sandhi shoola,sandhi stabdatha

时间窗: • Before starting treatment – on 0th day | • After completion of the treatment – on 8th day | • Follow up period - 24th day.

次要结局

  • Reduction in CRP titer,RA factor titer & EULAR Score(• Before starting treatment – on 0th day)

研究者

发起方
Priyanka Kalal
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验